Hypera Stock

Hypera FCF Growth

The Year-over-Year Free Cash Flow Growth of Hypera (HYPE3.SA) as of Aug 21, 2026 is 0.44 %. In the previous year, Year-over-Year Free Cash Flow Growth was 11.62 % — a change of -96.23% (lower).

FCF Growth

0.44 %

YoY

-96.23%

Last updated:

Year-over-Year Free Cash Flow Growth of Hypera is 2026 0.44 % . Year-over-Year Free Cash Flow Growth of Hypera was 2025 11.62 % . It decreases by -96.23% lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Year-over-Year Free Cash Flow Growth of Hypera is 0.44 % in 2026.

On Eulerpool you can find the complete historical development of Year-over-Year Free Cash Flow Growth Hypera since 2006 – with annual values, charts, and detailed analysis.

FCF growth measures the percentage change in free cash flow. Growing FCF indicates improving cash generation capability.

To evaluate Year-over-Year Free Cash Flow Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Free Cash Flow Growth.

Year-over-Year Free Cash Flow Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Free Cash Flow Growth's Hypera historically and in real time.

Access this data via the Eulerpool API

Growth — Hypera

All Key Metrics — Hypera